• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last half-hour
In the last hour
Magellan Denies Receiving MDO Tobacco Reporter Magazine08:56
In the last 2 hours
In the last 4 hours
In the last 6 hours
In the last 8 hours
Hugel reapplies for BTX approval in US Korea Biomedical Review02:30
Earlier today
Persisting illness The Financial Express00:05
Yesterday
Eli Lilly gets FDA’s speedy review for obesity drug South African Broadcasting Company16:02 6-Oct-22
FDA Issues Warning to Puff Bar, MDOs to Hyde Tobacco Reporter Magazine14:56 6-Oct-22
New Data Show More Than 2.5 Million U.S. Youth Currently Use E-Cigarettes U.S. Food and Drug Administration (Press Release)13:04 6-Oct-22
FDA and Institute for Government debate restoring trust in politics The FDA Trade Union (Press Release)11:29 6-Oct-22
Evofem Biosciences Announces Approval of Phexxi in Nigeria PR Newswire (Press Release)08:53 6-Oct-22
Diagnostic approval facilitates more cancer patients treatment European Pharmaceutical Review07:25 6-Oct-22
Orphan Drugs Market Size to Hit USD 340.84 Billion by 2027 GlobeNewswire (Press Release)05:56 6-Oct-22
The Shelves Have Eyes Drug & Device Law05:05 6-Oct-22
NAFDAC And Unregistered Herbal Products Independent Nigeria01:09 6-Oct-22
In the last 7 days
view more headlines
7 Oct 09:28

FDA News

NewsNow brings you the latest news from the world’s most trusted sources on the Food and Drug Administration. NewsNow aims to be the world’s most accurate and comprehensive FDA news aggregator, bringing you the latest headlines automatically and continuously 24/7. N.B. Relevance is automatically assessed so some headlines not qualifying as FDA news might appear - please feel free to contact us regarding any persistent issues.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.